Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 45, Pages 12787
Publisher
Baishideng Publishing Group Inc.
Online
2015-12-06
DOI
10.3748/wjg.v21.i45.12787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease
- (2015) Ludovico Abenavoli et al. Expert Review of Gastroenterology & Hepatology
- Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
- (2014) Ludovico Abenavoli WORLD JOURNAL OF GASTROENTEROLOGY
- Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease
- (2013) Brice Sid et al. BIOCHEMICAL PHARMACOLOGY
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation
- (2012) Massimo Collino et al. BIOCHEMICAL PHARMACOLOGY
- The Inflammasome Puts Obesity in the Danger Zone
- (2012) Rinke Stienstra et al. Cell Metabolism
- Sterile Inflammation in the Liver
- (2012) Paul Kubes et al. GASTROENTEROLOGY
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
- (2012) Geoffrey C. Farrell et al. Gut and Liver
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2012) Yoshihisa Takahashi WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Roles of PPARs in NAFLD: Potential therapeutic targets
- (2011) Anne Tailleux et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
- (2011) Anabela P. Rolo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
- (2011) Timea Csak et al. HEPATOLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
- (2011) S. Normand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
- (2010) Sarah L. Kempster et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo
- (2010) Shuangxi Wang et al. CIRCULATION RESEARCH
- Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8
- (2010) Ahmed Abu Shanab et al. DIGESTIVE DISEASES AND SCIENCES
- Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells
- (2010) Teresa Coll et al. ENDOCRINOLOGY
- Signaling by ROS drives inflammasome activation
- (2010) Fabio Martinon EUROPEAN JOURNAL OF IMMUNOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia
- (2010) Julieta Carabelli et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model
- (2009) Maria Soledad Rosselli et al. ATHEROSCLEROSIS
- Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model
- (2009) Hiroshi Kudo et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
- (2008) Raj Vuppalanchi et al. HEPATOLOGY
- Resistance to diet-induced obesity in mice with a single substituted chromosome
- (2008) David A. Buchner et al. PHYSIOLOGICAL GENOMICS
- Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle
- (2008) Pieter de Lange et al. PPAR Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started